Pei Lim Lee, MD
Transplant Hepatology · Los Angeles, CANPI 1982947131
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $66,935 of the $79,229 with a category attached, or 84.5%. 6 manufacturers reported payments, led by GSK at 57.9% of the total. Reporting peaked in 2024 at $51,451 and has fallen 97.5% since, to $1,310 in 2025. Among transplant hepatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $3444.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$46K
- Ipsen Bioscience Inc.$15K
- Gilead$14K
- Corcept Therapeutics$3K
- Spectrum Pharmaceuticals Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$24
What the payments were for
- Consulting fees$66,93584%
- Travel & lodging$11,93915%
- Food & beverage$3550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $45,869 |
| Ipsen Bioscience Inc. | 1 | $15,300 |
| Gilead | 1 | $13,875 |
| Corcept Therapeutics | 1 | $2,850 |
| Spectrum Pharmaceuticals Inc. | 1 | $1,310 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,229 in reported general payments places this provider in the 95th percentile of 39 transplant hepatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in Los Angeles
- Julio GutierrezLos Angeles$895K
- Beshoy YannyLos Angeles$50K
- Kali ZhouLos Angeles$50K
- Jasleen SinghLos Angeles$46K
- Norah TerraultLos Angeles$13K
- Jeffrey KahnLos Angeles$9K
- Brian KimLos Angeles$7K
- Tse Ling FongLos Angeles$6K
- Liyun YuanLos Angeles$4K
- Cynthia CherfaneLos Angeles$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.